22 completed, 11 recruiting, 3 not yet recruiting, 2 unknown. 17 Phase 1, 12 Phase 2, 6 Phase 3, 5 Phase 4, 1 Early Phase 1.
Follow Shanghai Institute Of Biological Products: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase Ib/IIa Clinical Trial of SIBP-A16 Injection in Premature Infants and Full-term Infants SIBP-A16 injection, Nirsevimab, SIBP-A16 buffer solution - Respiratory Syncytial Virus (RSV) | Phase 1 / Phase 2 | Not yet recruiting | Shanghai Institute Of Biological Products | 36 | 2026-01-15 | 2026-01-23 |
| Phase Ⅱ Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above Influenza virus split vaccine (0.7mL/vial), Influenza virus split vaccine - Influenza | Phase 2 | Not yet recruiting | Shanghai Institute Of Biological Products | 1200 | 2026-01-07 | 2026-01-15 |
| Evaluate the Safety and Immunogenicity of the MVA-SIBP Vaccine in the Democratic Republic of the Congo MVA-SIBP low dose, MVA-SIBP high dose, MVA-BN - Monkeypox (Mpox) | Phase 2 | Not yet recruiting | Shanghai Institute Of Biological Products | 180 | 2025-12-31 | 2025-11-28 |
| A Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above Influenza virus split vaccine (0.7mL/vial), Influenza virus split vaccine, Phosphate buffer solution (PBS) - Influenza | Phase 1 | Recruiting | Shanghai Institute Of Biological Products | 120 | 2025-12-16 | 2026-01-14 |
| A Clinical Trial of SIBP-A10 Injection in the Treatment of Advanced Malignant Tumor Subjects. SIBP-A10 - Advanced Tumors | Phase 1 | Recruiting | Shanghai Institute Of Biological Products | 160 | 2025-10-31 | 2026-01-08 |
| A Clinical Trial of SIBP-A16 Injection in Healthy Adults SIBP-A16 injection, Nirsevimab, SIBP-A16 buffer solution - Respiratory Syncytial Virus (RSV) | Early Phase 1 | Recruiting | Shanghai Institute Of Biological Products | 140 | 2025-08-17 | 2025-11-25 |
| A Clinical Trial of SIBP-A18 Injection in the Treatment of Advanced Malignant Solid Tumor Patients SIBP-A18 - Solid Tumor Malignancy | Phase 1 | Recruiting | Shanghai Institute Of Biological Products | 156 | 2025-06-16 | 2026-01-07 |
| A Clinical Trial of SIBP-A19 Injection in the Treatment of Advanced Malignant Solid Tumor Patients SIBP-A19 - Advanced Solid Tumors | Phase 1 | Recruiting | Shanghai Institute Of Biological Products | 156 | 2025-06-11 | 2026-01-08 |
| A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals Recombinant herpes zoster vaccine with low-dose adjuvant, Recombinant herpes zoster vaccine with high-dose adjuvant, Low-dose adjuvant - Herpes Zoster (HZ) | Phase 1 / Phase 2 | Recruiting | Shanghai Institute Of Biological Products | 645 | 2025-04-04 | 2026-01-07 |
| A Study Evaluating the Safety and Immunogenicity of MVA Strain Monkeypox Attenuated Live Vaccine MVA strain monkeypox attenuated live vaccine (low dose), MVA strain monkeypox attenuated live vaccine (high dose), Placebo - Monkeypox | Phase 1 | Recruiting | Shanghai Institute Of Biological Products | 120 | 2025-01-22 | 2025-10-03 |
| Clinical Trial of SIBP-03 in Patients With Head and Neck Squamous Cell Carcinoma HER3 Monoclonal antibodies-Dose A, HER3 Monoclonal antibodies-Dose B, HER3 Monoclonal antibodies-Dose C - Head and Neck Squamous Cell Carcinoma | Phase 2 | Recruiting | Shanghai Institute Of Biological Products | 81 | 2024-09-27 | 2026-01-16 |
| A Clinical Trial of SIBP-A17 Injection in the Treatment of Advanced Solid Tumor Patients. SIBP-A17 - Advanced Solid Tumor | Phase 1 | Recruiting | Shanghai Institute Of Biological Products | 196 | 2024-07-23 | 2026-01-07 |
| Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months SIBP MMR Vaccine, GSK MMR Vaccine (PRIORIX), Yellow Fever Vaccine (Stamaril) - Measles-Mumps-Rubella | Phase 3 | Completed | Shanghai Institute Of Biological Products | 1200 | 2024-06-28 | 2026-01-08 |
| A Clinical Trial of SIBP-A13 Injection in the Treatment of Advanced Malignant Solid Tumor Patients. SIBP-A13 formulation for injection - Advanced Solid Tumor | Phase 1 | Recruiting | Shanghai Institute Of Biological Products | 144 | 2024-05-09 | 2026-01-07 |
| A Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above. Quadrivalent influenza virus split vaccine (MDCK cells), Quadrivalent influenza virus split vaccine (Chicken embryo), Phosphate buffer solution - Influenza | Phase 1 | Completed | Shanghai Institute Of Biological Products | 300 | 2024-03-30 | 2025-02-19 |
| A Phase Ib Clinical Trial of Peguricase for Injection With Methotrexate in Patients With Uncontrolled Gout. SIBP-R002, Methotrexate - Gout | Phase 1 | Recruiting | Shanghai Institute Of Biological Products | 36 | 2023-03-03 | 2026-01-08 |
| A Study Exploring Efficacy of Peginterferon in Patients With Herpes Zoster Peginterferon α1b, Peginterferon α1b with valacyclovir, Valacyclovir - Herpes Zoster | Phase 2 | Completed | Shanghai Institute Of Biological Products | 50 | 2022-10-11 | 2023-12-29 |
| Immunogenicity and Safety of BBIBP-Corv Coadministered With PPV23 and IIV4 in Hemodialysis Population coadministration, COVID-19 vaccine, IIV4+PPV23 - Hemolysis, COVID-19 | Phase 4 | Unknown | China National Biotec Group Company Limited | 1200 | 2022-08-05 | 2022-08-30 |
| A Study Exploring Efficacy of Pegloticase in Subjects With Asymptomatic Hyperuricemia SIBP-R002, Dexamethasone or Methyl prednisolone, Diphenhydramine - Asymptomatic Hyperuricemia | Phase 1 | Completed | Shanghai Institute Of Biological Products | 45 | 2022-04-11 | 2023-12-27 |
| Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old Live attenuated varicella vaccines manufactured by Shanghai Institute of Biological Products Co.,Ltd., Live attenuated varicella vaccines manufactured by Changchun BCHT Biotechnology Co.,Ltd - Varicella | Phase 3 | Completed | Shanghai Institute Of Biological Products | 2480 | 2022-02-13 | 2023-12-29 |
Showing 20 of 38. Sign in to see all of them.
Influenza, Human (10) · Herpes Zoster (4) · Chickenpox (2) · Mpox, Monkeypox (2) · COVID-19 (1) · Gout (1) · Hemolysis (1) · Hyperuricemia (1) · Lymphoma, Large B-Cell, Diffuse (1) · Measles (1) · Mumps (1) · Neoplasms (1) · Neuralgia, Postherpetic (1) · Pneumococcal Infections (1) · Premature Birth (1)
Influenza Vaccines (3) · Bevacizumab (2) · Carboplatin (2) · Injections (2) · nirsevimab (2) · 23-valent pneumococcal capsular polysaccharide vaccine (1) · Adjuvants, Pharmaceutic (1) · COVID-19 Vaccines (1) · Cetuximab (1) · Chickenpox Vaccine (1) · Dexamethasone (1) · Diphenhydramine (1) · Docetaxel (1) · Measles-Mumps-Rubella Vaccine (1) · Methotrexate (1)
China (35) · Kenya (1)
Yeqing Tong (2) · Aidong Qu, Master (1) · Caicun Zhou, Doctor (1) · Guohua Li (1) · Hanwen Liu (1) · Hongxing Pan (1) · Hu Yuemei, PhD (1) · Huan Zhou (1) · Huan Zhou, Master (1) · Hypolite Muhindo Mavoko (1) · Jiang Wu, Master (1)
PMID 25110632, PMID 28547525, PMID 30002437, PMID 37452849, PMID 40697509